Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:JRDC?
Track your performance easily
GB:JRDC Price & Analysis
JRDC ETF Chart & Stats
Day’s Range― - ―
52-Week Range$15.31 - $23.14
Previous Close$19.02
VolumeN/A
Average Volume (3M)1.50K
AUM8.58M
NAV19.26
Expense Ratio0.40%
Holdings Count311
Beta0.43
Inception DateFeb 15, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.07
10 Day Avg. Volume138
30 Day Avg. Volume1,495
Alpha-0.00736
China A Research Enhanced Index Equity (ESG) UCITS ETF -USD- (JRDC) Fund Flow Chart
China A Research Enhanced Index Equity (ESG) UCITS ETF -USD- (JRDC) 1 year Net Flows: $459K
JRDC ETF FAQ
What was GB:JRDC’s price range in the past 12 months?
GB:JRDC lowest ETF price was $15.30 and its highest was $23.14 in the past 12 months.
What is the AUM of GB:JRDC?
As of Nov 12, 2024 The AUM of GB:JRDC is 8.58M.
Is GB:JRDC overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does GB:JRDC pay dividends?
GB:JRDC does not currently pay dividends.
How many shares outstanding does GB:JRDC have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:JRDC?
Currently, no hedge funds are holding shares in GB:JRDC
Top 10 Holdings
Kweichow Moutai Co., Ltd. Class A
5.08%
Contemporary Amperex Technology Co., Ltd. Class A
3.06%
China Merchants Bank Co., Ltd. Class A
2.14%
China Yangtze Power Co., Ltd. Class A
1.82%
Ping An Insurance (Group) Company of China, Ltd. Class A
1.80%
Wuliangye Yibin Co., Ltd. Class A
1.56%
CITIC Securities Co. Ltd. Class A
1.40%
BYD Company Limited Class A
1.39%
Agricultural Bank of China Limited Class A
1.18%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A
1.11%
Total20.54%
ETF Description
China A Research Enhanced Index Equity (ESG) UCITS ETF -USD-
The objective of the Sub-Fund is to achieve a long-term return in excess of the Benchmark by actively investing primarily in a portfolio of Chinese companies.